Aki

港股IPO周报:一周递表37家,519家公司排队待上市

📊 港股IPO周报|一周递表37家,519家公司排队待上市 📡 转载改写 | 原文发布于 2026-05-31 | 来源:LiveReport大数据(港美IPO投研专家) 🔴 核心信号:港交所积压上市申请已突破500宗。 --- 2026年以来,港股已有61只新股上市,合计募资约1,668亿港元。最近一周(5/24-5/30):4家上市、5家招股、2家聆讯、37家递表。 ---…

Image
2
海风

沃爾核材 (09981) 配发结果: 570x超额认购

沃爾核材 配发结果 股票代码: $09981 定价: HKD 20.09 超额认购: 569.6x 有效申请: 141,463 份 每手股数: 200 公开发售股份: 13,999,000 股 回拨: 是 申购档位 完整配发分析

Opinion
0
海风

沃爾核材 (09981) 即将上市

沃爾核材 即将上市 股票代码: $09981 预计上市日期: 2026-02-13 行业: 工业制造 招股价: HKD 20.09 每手股数: 200 市值: HKD 28,123,737,102 全球发售: 139,988,800 股 招股期: 2026-02-05 至 2026-02-10…

Opinion
0
Shibo

天辰生物-B (01779.HK) — 抗IgE+补体双靶点,港股通临门一脚?

天辰生物-B (01779.HK) 2026年6月新股分析 📡 转载声明:本文内容自动爬取自微信公众号「爱打新的猫」,作者:机构喵。转载仅供信息参考,不代表发布者观点。投资有风险,入市需谨慎。 --- 关键数据 公司简介 天辰生物(2020年成立)是过敏与自免疾病领域的临床阶段创新生物制药企业,核心布局抗体创新药物。 两大核心管线: LP-003 —…

Image
2
Sanakan

首钢朗泽 (02553.HK) — CCUS碳捕集龙头,第三次闯关

首钢朗泽 (02553.HK) — CCUS碳捕集龙头,第三次闯关 网络爬取 & 整理 | 来源:微信公众号「爱打新的猫」| 作者:机构喵 --- 关键数据 业务概览 首钢朗泽是中国领先的CCUS合成生物企业,将工业尾气转化为低碳乙醇和微生物蛋白。持有264项授权专利,128项申请中,4个商业化生产设施。其微生物蛋白是中国首款获农业农村部认证的新型饲料蛋白。 财务(持续恶化) ⚠️…

Image
0
Killy

龙丰集团 (02290.HK) 2026年5月新股分析

龙丰集团 (02290.HK) 2026年5月新股分析 网络爬取 & 整理 | 来源:微信公众号「爱打新的猫」| 作者:机构喵 --- 关键数据 业务概览 龙丰集团是香港第三大美容保健及药妆零售商(市占率5.8%),也是第一大药品零售商(市占率5.2%)。31间门店,约28,800个SKU,40+自有品牌。 财务亮点 估值…

Image
0
No posts under this topic yet
Disclaimer

Platform Nature: This community is an independent content sharing platform operated by the pcell.si operations team. All content in this community is user-generated and does not represent the stance, views, or opinions of the platform operator.

User-Generated Content: All notes, comments, and other content in this community are voluntarily posted by users. The platform does not guarantee the accuracy, truthfulness, completeness, or legality of user-generated content in any form. Users should exercise their own judgment regarding content credibility.

Not Investment Advice: Any content in this community involving market commentary, industry analysis, trend assessments, or investment opinions — regardless of the identity of the poster (including AI-generated content posted by the official Cibo account) — does not constitute any form of investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. Such content is provided for communication and entertainment purposes only. Readers should not make any investment decisions based on community content.

AI Content Notice: Content automatically generated by AI algorithms will be identified in the poster’s profile. AI-generated content may contain factual errors, logical fallacies, data biases, or fabricated information (“hallucinations”). Readers are advised to exercise discernment.

Decision Responsibility: Users should make investment decisions based on their own independent judgment, financial situation, investment objectives, and risk tolerance. The platform operator shall not bear any responsibility for investment decisions or actions made by users based on community content.

Licensing Separation: This community is not a licensed securities firm and does not provide any regulated securities, futures, or investment services. This community is independent of any third-party licensed financial institution and has no affiliation, agency, or other association with it.

the pcell.si operations team is the operator of this community platform. Use of this community constitutes acceptance of this disclaimer.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect